Entheogen Resurgence (SERPNTS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05042765|
Recruitment Status : Recruiting
First Posted : September 13, 2021
Last Update Posted : September 27, 2021
For the purpose of this anonymous, observational pilot survey, the investigators will define "entheogens" as substances, generally derived from plants, that are ingested in order to impact one's consciousness for therapeutic, religious, or spiritual purposes. This survey will focus on the naturalistic use of entheogens and other substances including kambo, ayahuasca, hapé, bufo, and sananga typically used in specific cultural and spiritual contexts for healing. There are substantial limitations to what the healthcare community knows about the intentions, motivations, experiences, health behaviors, and demographics of people who decide to participate in entheogen therapy centers or retreats and their willingness to participate in future research studies.
The primary goal of this observational pilot survey is to collect self-reported, anonymous data from people who have opted to participate in entheogen therapy centers and retreats during the last five (5) years on the topics of their initial intentions, motivations, experiences, demographics, and willingness to participate in future entheogen research.
With the support of established therapy and retreat centers, the research team will aim to collect 100 survey responses from unique, unidentified individuals who have participated in some form of entheogen therapy or treatment during the last five (5) years. Those who choose to fill out the survey will be at least 18 years of age, fluent in English, and self-reporting participation in therapy or a retreat which utilized entheogens in a naturalistic setting in the past five (5) years.
|Condition or disease||Intervention/treatment|
|Psychedelic Experiences||Other: self-reported entheogen use|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Entheogen Resurgence - Surveying Entheogen Retreat Participants in Naturalistic Settings|
|Actual Study Start Date :||September 16, 2021|
|Estimated Primary Completion Date :||March 2022|
|Estimated Study Completion Date :||March 2022|
- Other: self-reported entheogen use
self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years
- Entheogen Use in Naturalistic Retreat & Therapeutic Settings [ Time Frame: Entheogen use will have occured within the last 5 years ]The primary outcome will be self-reported experiences related to entheogen use in naturalistic retreat and therapeutic settings.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05042765
|Contact: Olivia M Uhley, BAfirstname.lastname@example.org|
|Contact: Stephen Dahmer, MDemail@example.com|
|Principal Investigator:||Stephen Dahmer, ND||Resurgent Biosciences, Inc.|